Navigate this market better. Subscribe for FREE stock alerts and information.

Monday, January 6, 2014

Belgium's Arseus sells units to U.S. group Henry Schein, (NASDAQ: HSIC)

Belgian healthcare group Arseus has sold several small units of its healthcare supplies business to U.S. group Henry Schein for 50 million euros ($68.07 million), the company said on Monday. Arseus sold its dental software units Julie and Arseus Dental Lab as well as Arseus Dental Solutions Benelux and France Ouest, which have joint annual sales of about 70 million euros.In August, Arseus said that it was considering options for the group's Healthcare Solutions and Healthcare Specialities divisions, after sales for these businesses fell in the first half.The group had already disposed of its dental distribution activities in November and said on Monday it would make further announcements in the first half of 2014.

Henry Schein, Inc. is a provider of health care products and services to office-based practitioners. Shares of HSIC traded higher by 0.37% or $0.42/share to $113.91. In the past year, the shares have traded as low as $82.11 and as high as $116.07. On average, 345286 shares of HSIC exchange hands on a given day and today's volume is recorded at 201453.